Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The University of Liverpool in the United Kingdom is facing criticism after it used information about scientists’ research income and publication records to identify redundancies. In a statement to Nature’s news team, the university says that a five-year average of research income was used to identify researchers whose jobs could be at risk, and that “a range of factors that might remove colleagues from the pool of those potentially at risk were then considered, including the contribution of positive citation metrics where appropriate”. Critics say these quantitative measures of performance concentrate too much on publication records while failing to acknowledge other types of work, including teaching, committee work and peer review.
Paediatrician Rachel Levine has been sworn in as the assistant secretary for health, one of the top health roles in the United States. The former Pennsylvania health secretary is the highest-ranking openly transgender official in the country. Researchers familiar with her work laud her drive to improve the health of marginalized people through conventional public-health measures and by trying to remedy inequities arising from social and political factors. “COVID-19 has shown us the tip of the iceberg of the lack of health equity,” Levine told Nature last September.
Within just a few months, pharmaceutical firms have produced hundreds of millions of doses of COVID-19 vaccine. But the world needs billions — and as fast as possible. Companies say they could make enough vaccines to immunize most of the world’s population by the end of 2021. But this doesn’t take into account political delays in distribution, such as countries imposing export controls — or that the overwhelming majority of doses are going to wealthier countries. Discover how it might be possible to vaccinate the world, from unleashing the power of mRNA vaccines, to the battle for temporary intellectual-property relief.
A clinical trial of the Sinopharm vaccine in Peru has sparked outrage after researchers inoculated politicians and family members, violating trial regulations — and damaging public trust. The scandal emerged on 10 February, when local media revealed that in October 2020, then-president Martín Vizcarra had received two doses of the jab. It has triggered a series of high-profile resignations at universities and in government. The public had seen the vaccine trial, and a subsequent deal for 38 million Sinopharm vaccine doses, as a turning point in the battle against COVID-19.
A comprehensive review of the current literature reveals the prolonged effects of post-acute COVID-19 syndrome — also called long COVID. COVID-19 usually lasts no more than 4 weeks from the onset of symptoms, but some people experience complications such as fatigue, shortness of breath, ‘brain fog’ and chest pain for some time afterwards. “It is clear that care for patients with COVID-19 does not conclude at the time of hospital discharge,” surmise the authors. “It is crucial for healthcare systems and hospitals to recognize the need to establish dedicated COVID-19 clinics, where specialists from multiple disciplines are able to provide integrated care.”
Physician-scientist Martin Landray describes how he and Jeremy Farrar, director of the Wellcome Trust, planned the influential Recovery drug trial on a London bus in March 2020. (BBC | 7 min read)
Synthetic diamond, developed as an industrial work-horse, is increasingly used for sensing applications that make use of its unique quantum characteristics. Diamonds are so strong that they can protect fragile quantum states that would otherwise survive only in a vacuum or at ultra-cold temperatures. Engineers are mastering the art of growing diamonds with special properties and detecting their quantum spin, opening up applications in biosensing, magnetometry and quantum computing.
Stay tuned for a very special penguin-tastic adventure to celebrate one whole year since we started Leif Penguinson’s globe-spanning game of hide and seek.
In the meantime, we welcome your feedback on this newsletter. Please send your e-mails to briefing@nature.com.
